Akums Drugs And Stock Last Dividend Paid
| AKUMS Stock | 607.65 11.75 1.97% |
Akums Drugs and fundamentals help investors to digest information that contributes to Akums Drugs' financial success or failures. It also enables traders to predict the movement of Akums Stock. The fundamental analysis module provides a way to measure Akums Drugs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Akums Drugs stock.
Akums |
Akums Drugs and Company Last Dividend Paid Analysis
Akums Drugs' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, Akums Drugs and has a Last Dividend Paid of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Drug Manufacturers - Specialty & Generic (which currently averages 0.0) industry. This indicator is about the same for all India stocks average (which is currently at 0.0).
Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Akums Fundamentals
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 134.21 B | ||||
| Shares Outstanding | 157.39 M | ||||
| Shares Owned By Insiders | 82.61 % | ||||
| Shares Owned By Institutions | 5.14 % | ||||
| Price To Book | 18.53 X | ||||
| Price To Sales | 3.09 X | ||||
| Revenue | 42.31 B | ||||
| EBITDA | 4.96 B | ||||
| Book Value Per Share | 49.59 X | ||||
| Earnings Per Share | 0.08 X | ||||
| Number Of Employees | 7.39 K | ||||
| Market Capitalization | 130.91 B |
About Akums Drugs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Akums Drugs and's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Akums Drugs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Akums Drugs and based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Akums Stock
Akums Drugs financial ratios help investors to determine whether Akums Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Akums with respect to the benefits of owning Akums Drugs security.